150 related articles for article (PubMed ID: 20552152)
21. [Hyperthermic intraperitoneal chemotherapy at the primary gastrointestinal cancer operation].
Degett TH; Pommergaard HC; Gögenur I
Ugeskr Laeger; 2017 Mar; 179(12):. PubMed ID: 28330549
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
23. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
24. [OR minute myth : Guidelines for calculation of DRG revenues per OR minute].
Waeschle RM; Hinz J; Bleeker F; Sliwa B; Popov A; Schmidt CE; Bauer M
Anaesthesist; 2016 Feb; 65(2):137-47. PubMed ID: 26829952
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the Revenue Situation in Interventional Radiology Based on the Example of Peripheral Artery Disease in the Case of a DRG Payment System and Various Internal Treatment Charges.
Vogt FM; Hunold P; Haegele J; Stahlberg E; Barkhausen J; Goltz JP
Rofo; 2018 Apr; 190(4):348-358. PubMed ID: 29495050
[TBL] [Abstract][Full Text] [Related]
26. [Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].
Liu D; Wang H; Yuan ZX; Chen WW; Wu ZJ; Liu XX; Luo J; Chu LL; Li Y; Cai J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):256-263. PubMed ID: 34645170
[No Abstract] [Full Text] [Related]
27. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastases from Endometrial Cancer.
Cornali T; Sammartino P; Kopanakis N; Christopoulou A; Framarino Dei Malatesta M; Efstathiou E; Spagnoli A; Ciardi A; Biacchi D; Spiliotis J
Ann Surg Oncol; 2018 Mar; 25(3):679-687. PubMed ID: 29282600
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
30. [Cost recovery for the treatment of retinal and vitreal diseases by pars plana vitrectomy under the German DRG system].
Framme C; Franz D; Mrosek S; Helbig H
Ophthalmologe; 2007 Oct; 104(10):866-74. PubMed ID: 17882428
[TBL] [Abstract][Full Text] [Related]
31. Impact of extent of disease on 1-year healthcare costs in patients who undergo cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: retrospective observational cohort study.
Kooijman BJL; Hentzen JEKR; van der Hilst CS; Been LB; van Ginkel RJ; Hemmer PHJ; Klaase JM; Kruijff S
BJS Open; 2020 Oct; 4(5):954-962. PubMed ID: 32652904
[TBL] [Abstract][Full Text] [Related]
32. Cytoreduction with hyperthermic intraperitoneal chemotherapy: an appraisal of outcomes and cost at a newly established peritoneal malignancy program.
Hinkle NM; MacDonald J; Sharpe JP; Dickson P; Deneve J; Munene G
Am J Surg; 2016 Sep; 212(3):413-8. PubMed ID: 27086201
[TBL] [Abstract][Full Text] [Related]
33. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
34. [Cost calculations for treating penetrating eye injuries within the DRG C01Z at a university eye hospital].
Framme C; Franz D; Mrosek S; Helbig H; Sachs HG
Ophthalmologe; 2008 Oct; 105(10):936-42. PubMed ID: 18351359
[TBL] [Abstract][Full Text] [Related]
35. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
36. The cost of cytoreductive surgery and perioperative intraperitoneal chemotherapy in the treatment of peritoneal malignancy in one Greek institute.
Tentes AA; Pallas N; Korakianitis O; Mavroudis C; Spiridonidou A; Zorbas G; Popidis S; Papadoniou N; Darladima V; Smyrnis A; Siopis C
J BUON; 2012; 17(4):776-80. PubMed ID: 23335540
[TBL] [Abstract][Full Text] [Related]
37. Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results.
Roviello F; Roviello G; Petrioli R; Marrelli D
Crit Rev Oncol Hematol; 2015 Sep; 95(3):297-305. PubMed ID: 25900072
[TBL] [Abstract][Full Text] [Related]
38. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.
Teo MC; Tan GH; Tham CK; Lim C; Soo KC
Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144
[TBL] [Abstract][Full Text] [Related]
40. Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program.
Jafari MD; Halabi WJ; Stamos MJ; Nguyen VQ; Carmichael JC; Mills SD; Pigazzi A
JAMA Surg; 2014 Feb; 149(2):170-5. PubMed ID: 24352601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
